Erythropoietic-stimulating agents (ESAs): new safety warning.
Zarowitz
Barbara J
BJ
Professional Services, Omnicare Inc.
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004334:Drug Administration Schedule; D004345:Drug Industry; D004348:Drug Labeling; D016903:Drug Monitoring; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D017751:Safety Management / Q000458:organization & administration*; D014481:United States; D014486:United States Food and Drug Administration
D004921:Erythropoietin